🔗 Share this article

Chancellor Reeves has stated she is planning "specific action to address cost of living challenges" in the upcoming financial statement.

Speaking to the BBC, she stated that reducing price rises is a joint duty of both the administration and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could intervene to reduce energy bills, for instance by slashing the present 5% rate of VAT applied on energy.

An additional possibility is to lower some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Expert Expectations

The government will obtain the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much space there is for such actions.

The expectation from the majority of economists is that the Chancellor will have to declare tax rises or budget cuts in order to fulfill her voluntary borrowing rules.

Previously on Thursday, estimates suggested there was a £22bn shortfall for the Treasury chief to address, which is at the lower end of forecasts.

"It is a joint task between the central bank and the administration to bear down further on some of the causes of price increases," Reeves stated to the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and International Concerns

While much of the focus has been on probable tax rises, the Treasury chief said the most recent figures from the OBR had not changed her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with increasing geopolitical and commercial issues for the fiscal revenue measures, probably to be focused on those "most able to pay."

Global Trade Disputes

Addressing concerns about the United Kingdom's commercial links with China she said: "Our national security invariably take priority."

Last week's statement by Chinese authorities to tighten trade restrictions on rare earths and other resources that are crucial for high-technology production led US President the US President to threaten an extra 100% tariff on goods from the Asian country, raising the possibility of an all-out trade war between the two global powers.

The US Treasury Secretary described China's action "economic coercion" and "a global supply chain control attempt."

Inquired about accepting the US offer to participate in its dispute with China, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the action was "harmful for the world economy and creates further challenges."

"It is my opinion there are fields where we must confront Chinese policies, but there are also important prospects to trade with China's economy, including banking sector and other sectors of the economy. We've got to achieve that equilibrium right."

The chancellor also affirmed she was cooperating with G7 counterparts "on our own critical minerals plan, so that we are more independent."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the cost the NHS pays for drugs could go up as a result of current discussions with the US government and its drugs companies, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or abandoning investments in the UK, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the health service pays for drugs would must rise to halt companies and drug research funding departing from the United Kingdom.

Reeves informed the BBC: "We have seen as a result of the cost structure, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the way that they are in other EU nations."

"The objective is to ensure that individuals getting care from the NHS are able to access the top essential medicines in the globe. And so we are reviewing these issues, and... seeking to obtain additional funding into Britain."